Company intelligence / Profile preview

KeraVet Bio

Winston-Salem, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

KeraVet Gel has demonstrated improved healing outcomes, reduced wound licking by 85%+, and decreased inflammation and edema versus traditional ointment in clinical studies

Therapeutic areas: Dermatology
Modalities: Hydrogel-based drug delivery therapyBiologic (keratin-based hydrogel)
Industry: Veterinary

Partnerships

epiq Animal Health (distribution)CovetrusPatterson VeterinaryVictor Medical CompanyMWI Animal HealthMidwest Veterinary Supply (major distributors)

Beyond the preview

Go deeper on KeraVet Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KeraVet Bio.

Explore the full profile